Nuvectis Pharma Investor Presentation Deck
Forward Looking Statements
Nuvectis Pharma, Inc.
Certain statements in this presentation constitute "forward-looking statements" within the meaning of the federal securities laws, which statements are
subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking
statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate," "believe,"
"contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "target," "aim," "should," "will," "would," or
the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements
are based on Nuvectis Pharma, Inc.'s current expectations, estimates, and projections about future events and trends that we believe may affect our
business, financial condition, results of operations, prospects, business strategy, and financial needs. The outcome of the events described in these
forward-looking statements are subject to inherent uncertainties, risks, assumptions, market and other conditions, and other factors that are difficult to
predict and include statements regarding the preclinical data generated to date for NXP800 and NXP900, the Phase 1a data generated for NXP800 and
the clinical expectations for the NXP800 Phase 1b study, including statements regarding NXP800's potential ability to become a therapeutic option for
the treatment of platinum-resistant, ARID1a-mutated ovarian carcinoma, gastric carcinoma, cholangiocarcinoma, and potentially other cancer
indications, and timing for the commencement of and expectations for the Phase 1a study for NXP900. Further, certain forward-looking statements are
based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are subject to market and other
conditions and described more fully in the section titled "Risk Factors" in our 2022 Form 10-K filed with the Securities and Exchange Commission ("SEC").
However, these risks are not exhaustive and new risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and
uncertainties that could have an impact on the forward-looking statements contained in this press release or other filings with the SEC. Any forward-
looking statements contained in this press release speak only as of the date of this press release. We expressly disclaim any obligation or undertaking to
release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in
events, conditions or circumstances on which any such statement is based, except as may be required by law, and we claim the protection of the safe
harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.View entire presentation